LIVN LivaNova PLC
2026Q1 · CUSIP G5509L101 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
289
Δ holders QoQ
+17
Breadth percentile
Top 18%
Whale holders
147
Δ whales
+10
Inst. holding value
$3.7B
New positions
56
Closed positions
39
Price momentum (1Q)
—
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 18% | — | — |
| 2025Q3 | Top 19% | — | — |
| 2023Q3 | Top 17% | — | — |
| 2022Q1 | Top 13% | — | — |
| 2018Q3 | Top 5% | — | — |
| 2018Q2 | Top 19% | — | — |
| 2018Q1 | Top 19% | — | — |
Options Sentiment
Put holders
0
QoQ: -2
Call holders
1
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
40.4
EPS (TTM)
$1.96
EPS YoY
—
Revenue (TTM)
$1.4B
Revenue YoY
+12.4%
Net margin
7.5%
ROE
8.8%
Debt ratio
51.9%
FCF (TTM)
$161M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.